Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Capital Expenditures: 2019-2025

Historic Capital Expenditures for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $18,000.

  • Benitec Biopharma's Capital Expenditures was N/A to $6,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$121,000, marking a year-over-year change of. This contributed to the annual value of $18,000 for FY2025, which is 89.94% down from last year.
  • Latest data reveals that Benitec Biopharma reported Capital Expenditures of $18,000 as of FY2025, which was down 89.94% from $179,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Capital Expenditures registered a high of $221,000 during FY2021, and its lowest value of $1,000 during FY2023.
  • In the last 3 years, Benitec Biopharma's Capital Expenditures had a median value of $18,000 in 2025 and averaged $66,000.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 94.12% in 2022, then skyrocketed by 17,800.00% in 2024.
  • Benitec Biopharma's Capital Expenditures (Yearly) stood at $221,000 in 2021, then plummeted by 94.12% to $13,000 in 2022, then crashed by 92.31% to $1,000 in 2023, then soared by 17,800.00% to $179,000 in 2024, then plummeted by 89.94% to $18,000 in 2025.